CL Share Price Performance
CA$1.01
-0.43 (-29.86%)
62.9% undervalued intrinsic discount
CA$2.72
Fair Value
Price CA$1.01
AnalystConsensusTarget CA$2.72
AnalystLowTarget CA$2.35
AnalystHighTarget CA$2.66
Fair ValueCA$2.72
Share Pricen/a
Cresco Labs Inc. Stock Price
- 3 Narratives written by author
- 1 Comments on narratives written by author
- 11 Fair Values set on narratives written by author
CL Community Narratives
AN
Fair Value
·Fair Value CA$2.72 62.9% undervalued intrinsic discount
Expanding Legal Markets Will Spur Cannabis Consolidation
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
Fair Value
·Fair Value CA$2.35 57.0% undervalued intrinsic discount
Cannabis Markets Will Battle Price Compression While Gaining Cautious Relief
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value CA$2.66 62.1% undervalued intrinsic discount
Rising Cannabis Legalization And Wellness Trends Will Fuel Expansion
0users have liked this narrative
1users have commented on this narrative
0users have followed this narrative
Cresco Labs
62.1% undervalued intrinsic discount
Rising Cannabis Legalization And Wellness Trends Will Fuel Expansion
View narrativeAN
Updated 6 Aug
Cresco Labs
62.9% undervalued intrinsic discount
Expanding Legal Markets Will Spur Cannabis Consolidation
View narrativeAN
Updated 2 Jul
Cresco Labs
57.0% undervalued intrinsic discount
Cannabis Markets Will Battle Price Compression While Gaining Cautious Relief
View narrativeAN
Updated 18 Jun
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
CL: Q2 Outperformance And CFO Transition Will Shape Next Phase
Fair Value: CA$2.66 62.1% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
1 commentusers have commented on this narrative
0 likesusers have liked this narrative
AN
CL: Expanded Ohio Dispensary Footprint Will Support Future Upside Potential
Fair Value: CA$2.72 62.9% undervalued intrinsic discount
5 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
CL: Texas License And Expanded Ohio Stores Will Support Upside Skewed Profile
Fair Value: CA$2.35 57.0% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Cresco Labs Inc. Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
- -0.27
- 49.92%
- -15.50%
- 128.3%
About CL
- Founded
- n/a
- Employees
- 2900
- CEO
- WebsiteView website
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy’s brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.
